Ethanol extraction of Picrorhiza scrophulariiflora prevents renal injury in experimental diabetes via anti-inflammation action

Journal of Endocrinology

Volumn 200, Issue 3, 2009, Pages 347-355

  He, Li Juan ^a   Liang, Min ^a   Hou, Fan Fan ^a   Guo, Zhi Jian ^a   Xie, Di ^a   Zhang, Xun ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN 1; PICRORHIZA SCROPHULARIIFLORA EXTRACT; PLANT EXTRACT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG ISOLATION; GENE EXPRESSION; MACROPHAGE; MALE; MEDICINAL PLANT; NONHUMAN; OXIDATIVE STRESS; PICRORHIZA SCROPHULARIIFLORA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SOLVENT EXTRACTION; STREPTOZOCIN DIABETES;

ALBUMINURIA; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ETHANOL; KIDNEY; MALE; OXIDATIVE STRESS; PICRORHIZA; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RHIZOME;

EID: 67449114010     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0481     Document Type: Article

References (38)

1. Aoyama I, Shimokata K & Niwa T 2002 An oral adsorbent downregulates renal expression of genes that promote interstitial inflammation and fibrosis in diabetic rats. Nephron 92 635-651.
2. Chander R, Kapoor NK & Dhawan BN 1992 Picroliv, picroside-I and kutkoside from Picrorhiza kurrooa are scavengers of superoxide anions. Biochemical Pharmacology 44 180-183.
3. Cheng HF, Wang CJ, Moeckel GW, Zhang MZ, McKanna JA & Harris RC 2002 Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension. Kidney International 62 929-939.
4. Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC & Tesch GH 2004 Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney International 65 116-128.
5. Coimbra TM, Janssen U, Grone HJ, Ostendorf T, Kunter U, Schmidt H, Brabant G & Floege J 2000 Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney International 57 167-182.
6. Furuta T, Saito T, Ootaka T, Soma J, Obara K, Abe K & Yoshinaga K 1993 The role of macrophages in diabetic glomerulosclerosis. American Journal of Kidney Diseases 21 480-485.
7. Gao H & Zhou YW 2005 Inhibitory effect of picroside II on hepatocyte apoptosis. Acta Pharmacologica Sinica 26 729-736.
8. Guo ZJ, Niu HX, Hou FF, Zhang L, Fu N, Nagai R, Lu X, Chen BH, Shan YX, Tian JW et al. 2008 Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway. Antioxidants & Redox Signalling 10 1699-1712.
9. Ihm CG 1997 Monocyte chemotactic peptide-1 in diabetic nephropathy. Kidney International 60 S20-S22.
10. Kato S, Luyckx VA, Ots M, Lee KW, Ziai F, Troy JL, Brenner BM & MacKenzie HS 1999 Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats. Kidney International 56 1037-1048.
11. Kikuchi Y, Imakiire T, Yamada M, Saigusa T, Hyodo T, Hyodo N, Suzuki S & Miura S 2005 Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats. Nephrology, Dialysis, Transplantation 20 1573-1581.
12. Kunsch C & Medford RM 1999 Oxidative stress as a regulator of gene expression in the vasculature. Circulation Research 85 753-766.
13. Li JM, Mullen AM, Yun S, Wientjes F, Brouns GY, Thrasher AJ & Shah AM 2002 Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha. Circulation Research 90 143-150.
14. Li C, Yang CW, Park CW, Ahn HJ, Kim WY, Yoon KH, Suh SH, Lim SW, Cha JH, Kim YS et al. 2003 Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats. Kidney International 63 454-463.
15. Li HY, Hou FF, Zhang X, Chen PY, Liu SX, Feng JX, Liu ZQ, Shan YX, Wang GB, Zhou ZM et al. 2007a Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model. Journal of the American Society of Nephrology 18 528-538.
16. Li T, Liu JW, Zhang XD, Guo MC & Ji G 2007b The neuroprotective effect of picroside II from hu-huang-lian against oxidative stress. American Journal of Chinese Medicine 35 681-691.
17. Liu Y 2006 Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney International 69 213-217.
18. Livak KJ & Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2( - KDelta Delta C(T)) method. Methods 25 402-408.
19. Lott JA, Stephan VA & Pritchard KA Jr 1983 Evaluation of the Coomassie Brilliant Blue G-250 method for urinary protein. Clinical Chemistry 29 1946-1950.
20. Luper S 1998 A review of plants used in the treatment of liver disease: part 1. Alternative Medicine Review 3 410-421.
21. Navarro JF & Mora C 2005 Role of inflammation in diabetic complications. Nephrology, Dialysis, Transplantation 20 2601-2604.
22. Sassy-Prigent C, Heudes D, Jouquey S, Auberval D, Belair MF, Michel O, Hamon G, Bariety J & Bruneval P 1995 Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition. Laboratory Investigation 73 64-71.
23. Sassy-Prigent C, Heudes D, Mandet C, Belair MF, Michel O, Perdereau B, Bariety J & Bruneval P 2000 Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 49 466-475.
24. Schrijvers BF, De Vriese AS & Flyvbjerg A 2004 From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocrine Reviews 25 971-1010.
25. Shi XY, Hou FF, Niu HX, Wang GB, Xie D, Guo ZJ, Zhou ZM, Yang F, Tian JW & Zhang X 2008 Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology 149 1829-1839.
26. Shikata K & Makino H 2001 Role of macrophages in the pathogenesis of diabetic nephropathy. Contributions to Nephrology 134 46-54.
27. Smit HF, Kroes BH, van den Berg AJ, van der WD, van den WE, Beukelman CJ, van DH & Labadie RP 2000 Immunomodulatory and anti-inflammatory activity of Picrorhiza scrophulariiflora. Journal of Ethnopharmacology 73 101-109.
28. Stenvinkel P, Pecoits-Filho R & Lindholm B 2003 Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. Journal of the American Society of Nephrology 14 1927-1939.
29. Sugimoto H, Shikata K, Hirata K, Akiyama K, Matsuda M, Kushiro M, Shikata Y, Miyatake N, Miyasaka M & Makino H 1997 Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes 46 2075-2081.
30. Taal MW, Chertow GM, Rennke HG, Gurnani A, Jiang T, Shahsafaei A, Troy JL, Brenner BM & Mackenzie HS 2001 Mechanisms underlying renoprotection during renin-angiotensin system blockade. American Journal of Physiology. Renal Physiology 280 F343-F355.
31. Utimura R, Fujihara CK, Mattar AL, Malheiros DM, Noronha IL & Zatz R 2003 Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney International 63 209-216.
32. Wu X, Zha D, Xiang G, Zhang B, Xiao SY & Jia R 2006 Combined MMF and insulin therapy prevents renal injury in experimental diabetic rats. Cytokine 36 229-236.
33. Yagi K 1976 A simple fluorometric assay for lipoperoxide in blood plasma. Biochemical Medicine 15 212-216.
34. Yang J, Li P, Zhang YM & Liu P 2003 The parmacological effect of Picrohiza. Pharmaceutical Journal of Chinese People's Liberation Army 19 217-218.
35. Yang YH, Liu SX, Liu ZQ & Zhou ZM 2006 Effects of Picrorhizae extract on the expressions of adhension molecule on ischemia/reperfusion kidney. Guangdong Medical Journal 27 1806-1808.
36. Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J, Couser WG & Seidel K 1995 Cellular events in the evolution of experimental diabetic nephropathy. Kidney International 47 935-944.
37. Yozai K, Shikata K, Sasaki M, Tone A, Ohga S, Usui H, Okada S, Wada J, Nagase R, Ogawa D et al. 2005 Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions. Journal of the American Society of Nephrology 16 3326-3338.
38. Zhang HL, Hsia KC & Lou TC 1965 Botanical and pharmacognostical studies of the Chinese drug hu-huang-lien, rhizome picrorrhizae. Acta Pharmacologica Sinica 12 808-816.